Halthcare Analysts discuss the patiet community perspective on Friedreich’s Ataxia (relevant companies LRMR BIB PTCT LXEO DSGN) on an Analyst/Industry conference call to be held on October 3.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRMR:
- 3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
- Larimar Therapeutics price target lowered to $7 from $10 at Baird
- Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
- EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
- Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments